Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs
$0.3951
0.03(7.6%)
as of September 16, 2025
Try our APIs with
free plan!
Reviva Pharmaceuticals Holdings Inc. Financial Data Overview
Price chart is built with
Anychart
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Prev. Close
0.3951
Open
0.4284
High
0.4395
Low
0.3922
52 wk Range
0.3-2.99
Market Cap
26 950 K
Shares Outstanding
68 004 K
EPS
-0.12
Beta
-0.049
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Reviva Pharmaceuticals Holdings Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Reviva Pharmaceuticals Holdings Inc. data using free add-ons & libraries
Get Reviva Pharmaceuticals Holdings Inc. Fundamental Data
Reviva Pharmaceuticals Holdings Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -10 103 922
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.13
Get Reviva Pharmaceuticals Holdings Inc. End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Reviva Pharmaceuticals Holdings Inc. News
New
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Bristol Myers BMY won FDA approval for xanomelineand trospiumchloride (formerly KarXT), an oral medication for the treatment of schizophrenia in adults, in September 2024. The drug was approved under...
Reviva Narrows Loss 23% in Fiscal Q2
Key Points Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The c...
Reviva Pharmaceuticals GAAP EPS of -$0.12 in-line
* Reviva Pharmaceuticals press release [https://seekingalpha.com/pr/20202002-reviva-reports-second-quarter-2025-financial-results-and-recent-business-highlights] (NASDAQ:RVPH [https://seekingalpha.c...
Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights
– Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial– – Suc...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
